Improving Personal Recovery After Depression With a Blended Module (STAIRS)

Sponsor
University Medical Center Groningen (Other)
Overall Status
Recruiting
CT.gov ID
NCT05440812
Collaborator
Hanze University of Applied Sciences (Other)
140
2
2
23.6
70
3

Study Details

Study Description

Brief Summary

Almost all mental healthcare treatments of depression focus on symptomatic recovery. However, such recovery does not inherently mean that personal recovery is reached. In fact, many persons still experience functional impairments after symptomatic recovery. As this has a negative influence on daily life, a new blended module (STAIRS) was developed to promote personal recovery in persons that are in the final stage of symptomatic recovery from depression. The current study will investigate the efficacy of STAIRS, by adding STAIRS to care as usual and comparing it with care as usual. It is hypothesized that STAIRS will have a positive effect on personal recovery and that this effect is larger than in the control group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Storytelling and Training to Advance Individual Recovery Skills (STAIRS)
N/A

Detailed Description

The study uses a mixed methods design to determine efficacy and underlying mechanisms contributing to the effect of the STAIRS-training. One hundred forty adults, who are in the last phase of their depression treatment, will be enrolled and randomized (1:1) to (1) a group receiving the STAIRS-training next to Care as Usual (CAU) or (2) a group receiving CAU added with three information letters. Level of personal recovery, symptom severity, empowerment and control will be determined at baseline, at the end of the program (8 weeks) and at 6 months follow up. Approximately fifteen participants from the STAIRS group will be asked about their experiences with the different elements of the program and the perceived effects, in a semi-structured interview at the end of the program.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Efficacy of STAIRS will be assessed by conducting a randomized controlled trial (N=140). In this trial, participants will be randomly assigned either to the experimental group receiving care as usual complemented with the STAIRS-training or the control group receiving care as usual. Measurement points are at T0 (baseline), T1 (post-treatment) and T2 (6 months after end of treatment). Qualitative semi-structured interviews will be held in the experimental group at T1 about the value that participants assign to the elements of the training, as well as the experienced acceptability, and perceived usefulness of the training.Efficacy of STAIRS will be assessed by conducting a randomized controlled trial (N=140). In this trial, participants will be randomly assigned either to the experimental group receiving care as usual complemented with the STAIRS-training or the control group receiving care as usual. Measurement points are at T0 (baseline), T1 (post-treatment) and T2 (6 months after end of treatment). Qualitative semi-structured interviews will be held in the experimental group at T1 about the value that participants assign to the elements of the training, as well as the experienced acceptability, and perceived usefulness of the training.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of the Effectiveness of a Newly Developed Blended Module for Patients Recovering From Depression (STAIRS): a Mixed Methods Randomized Controlled Trial
Anticipated Study Start Date :
Jul 15, 2022
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Care As Usual plus STAIRS

Care as usual added with a eight week STAIRS-training

Behavioral: Storytelling and Training to Advance Individual Recovery Skills (STAIRS)
STAIRS is a 8-week program, in which 8 different themes are addressed. Coverage of each theme starts with a group meeting guided by a professional and expert by experience. In these meetings different exercises are done (e.g., filling out an actual and desired week-schedule, role-playing a difficult situation), information is given and experiences are shared. Between meetings, participants can choose from a range of homework exercises to practice their desired skills in a tailored way. In addition, participants can share experiences with the other group members and exchange reactions using a private online community.

No Intervention: Care As Usual

Care as usual added with three information letters

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in Inventory Recovery Outcome Counter (I.ROC) total score [Baseline, end of treatment (8 weeks) and 6 months follow up]

    The I.ROC is a self report rating scale containing 12 items measuring the level of personal recovery. Each item is rated on a 6-point ordinal scale, ranging from 0 (never) to 5 (always). Total scores range from 0 to 72. A higher score is better.

  2. Change from baseline in Recovery Assessment Scale, Domains and Stages (RAS-DS) total score [Baseline, end of treatment (8 week) and 6 months follow up]

    The RAS-DS is a self report rating scale containing 38 items measuring the level of personal recovery. Each item is rated on a 4-point ordinal scale, ranging from 0 (untrue) to 4 (completely true). Total scores range from 0 to 152. A higher score is better.

Secondary Outcome Measures

  1. Change from baseline in Inventory of Depressive Symptomatology - Self Report (IDS-SR) total score [Baseline, end of treatment (8 weeks) and 6 months follow up]

    The IDS-SR is a self report rating scale containing 30 items, of which 28 need to be answered, measuring the level of depressive symptom severity. Each item is rated on a 4-point ordinal scale, ranging from 0 to 3. Total scores range from 0 to 84. A higher score is worse.

  2. Change from baseline in Sheehan Disability Scale (SDS) total score [Baseline, end of treatment (8 week) and 6 months follow up]

    The SDS is a self report rating scale containing 5 items, measuring the level of global functional impairments caused by symptoms. Three items are rated on a 11-point ordinal scale, ranging from 0 (not at all) to 10 (extremely). Total scores range from 0 to 30. A higher score is worse. Furthermore two items measure the number of days lost or unproductive caused by symptoms.

  3. Depression relapse in the last six months, diagnosed with the Mini International Neuropsychiatric Interview (M.I.N.I), section A [6 months follow up]

    The M.I.N.I. is a structured diagnostic interview for diagnosing psychiatric disorders. Section A is used to diagnose the presence of a depressive episode in the past six months.

  4. Change from baseline in Netherlands Empowerment List (NEL) total score [Baseline, end of treatment (8 weeks) and 6 months follow up]

    The NEL is a self report rating scale containing 40 items measuring the level of empowerment. Each item is rated on a 5-point ordinal scale, ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 40 to 200. A higher score is better.

  5. Change from baseline in Mastery Scale total score [Baseline, end of treatment (8 weeks) and 6 months follow up]

    The Mastery Scale is a self report rating scale containing 7 items measuring the level of control over events and ongoing situations. Each item is rated on a 5-point ordinal scale, ranging from 0 (strongly disagree) to 4 (strongly agree). Total scores range from 0 to 28. A higher score is better.

  6. Change from baseline in Self-Management Ability Scale (SMAS-30) total score [Baseline, end of treatment (week 8) and 6 months follow up]

    The SMAS-30 is a self report rating scale containing 30 items measuring the level of self-management. Each item is rated on a 6-point ordinal scale, ranging from 1 to 6. Total scores range from 30 to 180. A higher score is better.

  7. Economic evaluation, based on the Treatment Inventory of Costs in Psychiatric patients [Baseline, end of treatment (8 weeks) and 6 months follow up]

    The TIC-P is a self report questionnaire measuring the medical costs and productivity losses caused by health problems related to psychiatric disorders.

  8. Perceived effects and program valuation by patients recovering from a depression [End of intervention (8 weeks)]

    User experiences on program elements considered helpful, investigated with a semi structured interview with selected participants from the STAIRS-group containing questions about what helped them in which way in their personal recovery process

  9. Acceptability and usability of the STAIRS-training for patients recovering from a depression [End of intervention (8 weeks)]

    User experiences on acceptability and usability, investigated with a semi structured interview containing questions about the content, didactics and organization of the meetings, homework assignments and used website.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 to 65 years old

  • Being in the last phase (recovery phase) of treatment for a diagnosed Major Depressive Disorder; psychological treatment is expected to end within three months or treatment is finished within the past 3 months and patient receives an aftercare and/or maintenance antidepressant treatment.

  • No more than moderate depression severity: Score of <38 on the Inventory of Depressive Symptomatology - Self Rated (IDS-SR).

  • The willingness to participate: an affirmative response to the question 'after being explained what participation means for you, are you willing to participate?'.

Exclusion Criteria:
  • Bipolar depression or depression with psychotic features.

  • Comorbid schizophrenia spectrum or other psychotic disorder.

  • Comorbid moderate or severe dependence of alcohol or drugs.

  • Neurological disorder (e.g., dementia).

  • Insufficient command of the Dutch language.

  • Cognitive problems or indication of low IQ (i.e.< 80).

  • Not in possession of a pc or smartphone.

  • Having been referred to a different mental health service for other mental problems

Contacts and Locations

Locations

Site City State Country Postal Code
1 GGZ Drenthe Assen Drenthe Netherlands 9401PJ
2 University Medical Center Groningen Groningen Netherlands 9713GZ

Sponsors and Collaborators

  • University Medical Center Groningen
  • Hanze University of Applied Sciences

Investigators

  • Principal Investigator: Robert Schoevers, prof, UMCG

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
University Medical Center Groningen
ClinicalTrials.gov Identifier:
NCT05440812
Other Study ID Numbers:
  • 202100347
First Posted:
Jul 1, 2022
Last Update Posted:
Jul 1, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Medical Center Groningen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 1, 2022